NL7604459A - Subcutaan inplanteerbare pil. - Google Patents

Subcutaan inplanteerbare pil.

Info

Publication number
NL7604459A
NL7604459A NL7604459A NL7604459A NL7604459A NL 7604459 A NL7604459 A NL 7604459A NL 7604459 A NL7604459 A NL 7604459A NL 7604459 A NL7604459 A NL 7604459A NL 7604459 A NL7604459 A NL 7604459A
Authority
NL
Netherlands
Prior art keywords
installable
pill
subcutaneous
subcutaneous installable
installable pill
Prior art date
Application number
NL7604459A
Other languages
English (en)
Dutch (nl)
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NL7604459A publication Critical patent/NL7604459A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7604459A 1975-04-28 1976-04-27 Subcutaan inplanteerbare pil. NL7604459A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/572,691 US3991750A (en) 1975-04-28 1975-04-28 Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals

Publications (1)

Publication Number Publication Date
NL7604459A true NL7604459A (nl) 1976-11-01

Family

ID=24288938

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7604459A NL7604459A (nl) 1975-04-28 1976-04-27 Subcutaan inplanteerbare pil.

Country Status (6)

Country Link
US (1) US3991750A (fr)
JP (1) JPS51133410A (fr)
BE (1) BE841166A (fr)
DE (1) DE2618129A1 (fr)
FR (1) FR2309212A1 (fr)
NL (1) NL7604459A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373279A1 (fr) * 1976-12-13 1978-07-07 Ici Ltd Composition a base d'un copolymere sequence pour la liberation prolongee d'un agent doue d'activite biologique

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209014A (en) * 1977-12-12 1980-06-24 Canadian Patents And Development Limited Dispensing device for medicaments
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US4326524A (en) * 1980-09-30 1982-04-27 Minnesota Mining And Manufacturing Company Solid dose ballistic projectile
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
NZ207341A (en) * 1984-03-01 1988-02-29 Harvey Alex Ind Ltd Device containing chemical impregnants for insertion into a body cavity of an animal
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
AP2000001805A0 (en) 1997-10-22 2000-06-30 Jens Ponikau Use of antifungal agents for the topical treatment of fungus-induced mucositis.
US6197324B1 (en) * 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
PT1300129E (pt) 1997-12-29 2005-07-29 Alza Corp Tubo para implante
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
US6197815B1 (en) 1998-03-18 2001-03-06 J.H. Biotech, Inc. Amino acid chelates to reduce still births and increase birth weight in non-human animals
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6251079B1 (en) 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US20030165614A1 (en) * 2002-03-01 2003-09-04 Henrik Hansen Coating a medical implant using a pan coater
WO2004058110A2 (fr) * 2002-12-24 2004-07-15 Ovion, Inc. Dispositif de contraception et systeme de distribution
US7572298B2 (en) * 2003-03-28 2009-08-11 Ethicon, Inc. Implantable medical devices and methods for making same
WO2005035717A2 (fr) * 2003-10-03 2005-04-21 Thorn Bioscience, Llc Processus de synchronisation de l'ovulation pour la reproduction reglee sans detection des chaleurs
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
US8235047B2 (en) 2006-03-30 2012-08-07 Conceptus, Inc. Methods and devices for deployment into a lumen
PT2054049E (pt) 2006-08-24 2016-06-02 Univ Tennessee Res Found Acilanilidas substituídas e métodos de utilização das mesmas
EP2421545B1 (fr) 2009-04-23 2017-12-06 JBS United Animal Health II LLC Procédé et composition pour synchroniser le moment de l'insémination
CN108143728A (zh) 2012-07-13 2018-06-12 Gtx公司 选择性雄激素受体调节剂在治疗乳癌中的用途
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
CN113398243A (zh) 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
WO2018064556A1 (fr) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Implant bioérodable pour l'administration de médicament à long terme et procédés de fabrication et d'utilisation associés
US20200171048A1 (en) * 2018-11-29 2020-06-04 lnsigna lnc. Prevention of boar taint and aggression
CN113423391A (zh) 2018-11-29 2021-09-21 因斯格纳公司 作为不育剂的苯甲酸雌二醇

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118915A (en) * 1959-02-24 1964-01-21 Syntex Corp 2alpha-lower alkyl dihydro testosterone and derivatives thereof
US3608549A (en) * 1970-01-15 1971-09-28 Merrill Edward Wilson Method of administering drugs and capsule therefor
US3857932A (en) * 1970-09-09 1974-12-31 F Gould Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3870791A (en) * 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US3867519A (en) * 1972-04-27 1975-02-18 Alza Corp Bioerodible drug delivery device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373279A1 (fr) * 1976-12-13 1978-07-07 Ici Ltd Composition a base d'un copolymere sequence pour la liberation prolongee d'un agent doue d'activite biologique

Also Published As

Publication number Publication date
BE841166A (fr) 1976-10-27
FR2309212A1 (fr) 1976-11-26
DE2618129A1 (de) 1976-11-11
JPS51133410A (en) 1976-11-19
US3991750A (en) 1976-11-16

Similar Documents

Publication Publication Date Title
NL7604459A (nl) Subcutaan inplanteerbare pil.
NL7604005A (nl) Infusieset.
NL7614262A (nl) Kauwbare tablet.
NL7607738A (nl) Hulselinbrenging.
NL7503814A (nl) Muntopvoerinrichting.
NO139456C (no) Drivladningstenner.
NL182533C (nl) Implanteerbaar voorwerp.
BE849303A (fr) Tranducteur.
NL173446C (nl) Tijdschakeling.
NL7510276A (nl) Elektronenmikroskoop.
ES218977Y (es) Acumulador.
NL7606143A (nl) Machinetimingsysteem.
NL7512942A (nl) Modulaire elementen.
DK151559C (da) Kartonaeske.
ES209316Y (es) Muneco mecanico.
ES212889Y (es) Cohete-senal.
ES209752Y (es) Estuche mejorado.
ES209904Y (es) Estuche.
ES210373Y (es) Estuche.
NL7608595A (nl) Extractietoestel.
NL7604617A (nl) Capsule.
ES212067Y (es) Un nivel.
ES209449Y (es) Arqueta sifonica.
ES212667Y (es) Arqueta sifonica.
ES209448Y (es) Arqueta sifonica.